Sabra Healthcare REIT (SBRA) has a ROE of 2.34%, below the Finance sector average of 16.62%.
Get informed when a big investor buys or sells
+ Follow2.34%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
Sabra Healthcare REIT (SBRA) currently reports a ROE of 2.34%. That is below the Finance sector average of 16.62%. Use the charts on this page to explore Sabra Healthcare REIT's ROE history and peer comparisons.
Sabra Healthcare REIT's ROE of 2.34% is lower than the Finance sector average of 16.62%. That is roughly 85.9% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' ROE, but Sabra Healthcare REIT's current 2.34% should be judged against Finance norms (sector average: 16.62%) and against SBRA's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current ROE of 2.34%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Finance average is 16.62%. From there, open related valuation or income-statement pages for Sabra Healthcare REIT, and consider following SBRA for alerts when major investors trade the stock.
Sabra Healthcare REIT is classified in the Finance sector. On ROE, it currently shows 2.34% versus a sector average near 16.62%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Finance are usually more informative than comparing SBRA with unrelated industries.